Chris Klein

Christopher Klein serves as General Counsel at Shionogi Inc. since May 2023, bringing extensive legal expertise from previous positions, including General Counsel at RVL Pharmaceuticals plc from December 2013 to May 2023, and at Fougera Pharmaceuticals Inc. during 2011 to 2012. Prior to these roles, Christopher held the position of Deputy General Counsel at King Pharmaceuticals, Inc. from 2005 to 2011 and worked as Senior Counsel for Biotechnology Patents and Transactions at Bristol-Myers Squibb from 1997 to 2005. Early career experience includes serving as Patent Counsel at ImmuLogic Pharmaceutical Corp. and Principal at the Law Office of Christopher A. Klein, alongside a clerkship at Morgan & Finnegan. Educational qualifications include a Juris Doctor from Fordham University School of Law, a Master's degree from Columbia University, and a Bachelor's degree from Adelphi University.